Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay - PubMed (original) (raw)
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay
S Harada et al. Science. 1985.
Abstract
The human T-cell lines MT-2 and MT-4 carry the human T-cell leukemia virus type I (HTLV-I). When MT-2 and MT-4 were infected with HTLV-III, the probable etiologic agent of the acquired immune deficiency syndrome (AIDS), rapid cytopathogenic effects and cytotoxicity were observed that made it possible to titrate the biologically active virus in a plaque-forming assay. The cytopathogenic effects were preceded by the rapid induction and increase of HTLV-III antigens as revealed by immunofluorescence and immunoprecipitation. Activities of HTLV-III were neutralized by the human antibodies against the virus when immunofluorescence and plaque assays were used. Essentially the same results were obtained with the lymphadenopathy-associated virus (LAV1).
Similar articles
- Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
Harada S, Koyanagi Y, Yamamoto N. Harada S, et al. Virology. 1985 Oct 30;146(2):272-81. doi: 10.1016/0042-6822(85)90010-8. Virology. 1985. PMID: 2413616 - Quantitative evaluations of the effect of UV irradiation on the infectivity of HTLV-III (AIDS virus) with HTLV-I-carrying cell line, MT-4.
Nakashima H, Koyanagi Y, Harada S, Yamamoto N. Nakashima H, et al. J Invest Dermatol. 1986 Aug;87(2):239-43. doi: 10.1111/1523-1747.ep12696622. J Invest Dermatol. 1986. PMID: 3016104 - Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H, Matsui T, Harada S, Kobayashi N, Matsuda A, Ueda T, Yamamoto N. Nakashima H, et al. Antimicrob Agents Chemother. 1986 Dec;30(6):933-7. doi: 10.1128/AAC.30.6.933. Antimicrob Agents Chemother. 1986. PMID: 2434024 Free PMC article. - Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
Markham PD, Shaw GM, Salahuddin SZ, Hahn B, Sarngadharan MG, Gallo RC. Markham PD, et al. Adv Exp Med Biol. 1985;187:13-34. doi: 10.1007/978-1-4615-9430-7_2. Adv Exp Med Biol. 1985. PMID: 2994417 Review. - Human T-cell leukemia virus specific antigens.
Lee TH, Coligan JE, Essex M. Lee TH, et al. Princess Takamatsu Symp. 1984;15:197-203. Princess Takamatsu Symp. 1984. PMID: 6100639 Review.
Cited by
- _trans_-IV restriction: a new configuration for metal bis-cyclam complexes as potent CXCR4 inhibitors.
Alzahrani SO, McRobbie G, Khan A, D'huys T, Van Loy T, Walker AN, Renard I, Hubin TJ, Schols D, Burke BP, Archibald SJ. Alzahrani SO, et al. Dalton Trans. 2024 Mar 19;53(12):5616-5623. doi: 10.1039/d3dt01729j. Dalton Trans. 2024. PMID: 38439632 Free PMC article. - HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors.
da Silva-Januário ME, da Costa CS, Tavares LA, Oliveira AK, Januário YC, de Carvalho AN, Cassiano MHA, Rodrigues RL, Miller ME, Palameta S, Arns CW, Arruda E, Paes Leme AF, daSilva LLP. da Silva-Januário ME, et al. Mol Cell Proteomics. 2023 Dec;22(12):100676. doi: 10.1016/j.mcpro.2023.100676. Epub 2023 Nov 7. Mol Cell Proteomics. 2023. PMID: 37940003 Free PMC article. - Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling.
Sales D, Lin E, Stoffel V, Dickson S, Khan ZK, Beld J, Jain P. Sales D, et al. NeuroImmune Pharm Ther. 2023 Mar 25;2(1):49-62. doi: 10.1515/nipt-2022-0017. Epub 2023 Feb 17. NeuroImmune Pharm Ther. 2023. PMID: 37027342 Free PMC article. - Monocyte-derived macrophages contain persistent latent HIV reservoirs.
Veenhuis RT, Abreu CM, Costa PAG, Ferreira EA, Ratliff J, Pohlenz L, Shirk EN, Rubin LH, Blankson JN, Gama L, Clements JE. Veenhuis RT, et al. Nat Microbiol. 2023 May;8(5):833-844. doi: 10.1038/s41564-023-01349-3. Epub 2023 Mar 27. Nat Microbiol. 2023. PMID: 36973419 Free PMC article. - Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
Kobayakawa T, Yokoyama M, Tsuji K, Fujino M, Kurakami M, Onishi T, Boku S, Ishii T, Miura Y, Shinohara K, Kishihara Y, Ohashi N, Kotani O, Murakami T, Sato H, Tamamura H. Kobayakawa T, et al. RSC Adv. 2023 Jan 12;13(3):2156-2167. doi: 10.1039/d2ra06837k. eCollection 2023 Jan 6. RSC Adv. 2023. PMID: 36712613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources